Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Suvarna A Wagh"'
Autor:
Janine R Neumann, Suvarna Dash-Wagh, Alexander Jack, Andrea Räk, Kay Jüngling, Mohammad I K Hamad, Hans-Christian Pape, Michael R Kreutz, Martin Puskarjov, Petra Wahle
Publikováno v:
PLoS ONE, Vol 14, Iss 2, p e0211151 (2019)
The 30-amino acid peptide Y-P30 corresponds to the N-terminus of the primate-specific, sweat gland-derived dermcidin prepropeptide. Previous work has revealed that Y-P30 enhances the interaction of pleiotrophin and syndecans-2/3, and thus represents
Externí odkaz:
https://doaj.org/article/5c2988e9542a4f6f8a161ca1f6c5a2f6
Autor:
Vishal N Kushare, Suvarna A Wagh
Publikováno v:
International Journal of Research in Phytochemistry and Pharmacology. 8:7-10
Oxidative Stress is the primary cause of most of the diseases currently in the world. The human body is prone to many illnesses out of which oxidative stress plays a significant role in the causation of those. The Stress in the body releases free rad
Autor:
Vishal N Kushare, Suvarna A Wagh
Publikováno v:
International Journal of Dermatopathology and Surgery. 6:17-22
Tuberculosis causes most number of deaths due to infections worldwide. Around 9.0 million new cases and 1.5 million deaths registered worldwide of which 360,000 were HIV positive. One fourth of the global TB encumbrance occurs in India, making it the
Autor:
Suvarna Dash-Wagh, Stefan Jacob, Staffan Lindberg, Anders Fridberger, Ülo Langel, Mats Ulfendahl
Publikováno v:
Molecular Therapy: Nucleic Acids, Vol 1, Iss C (2012)
RNA interference (RNAi) using short interfering RNA (siRNA) is an attractive therapeutic approach for treatment of dominant-negative mutations. Some rare missense dominant-negative mutations lead to congenital-hearing impairments. A variety of viral
Externí odkaz:
https://doaj.org/article/ac4dfda56966494cad74e7ea337a818e
Publikováno v:
Methods in Molecular Biology ISBN: 9781493931118
Gene silencing by small interfering RNA (SiRNA) is an attractive therapeutic approach for pathological disorders that targets a specific gene. However, its applications are limited, as naked RNA is rapidly degraded by RNases and is inadequately inter
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9200476ccabe8094aa655be70a64b2e5
https://doi.org/10.1007/978-1-4939-3112-5_3
https://doi.org/10.1007/978-1-4939-3112-5_3
Autor:
Suvarna Dash-Wagh, Petra Wahle, Christian Grote-Westrick, Sophie Veitinger, Peter Landgraf, Alexander von Holst, Hans-Christian Pape, Janine R. Neumann, Michael R. Kreutz
Publikováno v:
Molecular and Cellular Neuroscience. 48:195-204
Y-P30, the 30 amino acid N-terminal peptide of the dermcidin gene, has been found to promote neuronal survival and differentiation. Its early presence in development and import to the fetal brain led to the hypothesis that Y-P30 has an influence on p
Publikováno v:
Future Neurology. 4:5-8
Publikováno v:
Methods in molecular biology (Clifton, N.J.). 1364
Gene silencing by small interfering RNA (SiRNA) is an attractive therapeutic approach for pathological disorders that targets a specific gene. However, its applications are limited, as naked RNA is rapidly degraded by RNases and is inadequately inter
Autor:
Stefan Jacob, Suvarna Dash-Wagh, Ülo Langel, Mats Ulfendahl, Anders Fridberger, Staffan Lindberg
Publikováno v:
Molecular Therapy: Nucleic Acids, Vol 1, Iss C (2012)
Molecular Therapy. Nucleic Acids
Molecular Therapy. Nucleic Acids
RNA interference (RNAi) using short interfering RNA (siRNA) is an attractive therapeutic approach for treatment of dominant-negative mutations. Some rare missense dominant-negative mutations lead to congenital-hearing impairments. A variety of viral